Skip to main content


NeurogesX's CEO Discusses Q2 2012 Results - Earnings Call Transcript

NeurogesX's CEO Discusses Q2 2012 Results - Earnings Call Transcript

For Biotech, 'Fail' is Making a Big Comeback

A series of disappointments and setbacks is cooling off the once red-hot biotech sector.

Play TheStreet's FDA Drug-Approval Contest

The FDA will issue approval decisions on 17 drugs over the next four months. How well can you predict which drugs will be approved or rejected?

27 Hot Drugs Facing FDA Approval in 2012

These are the biotech and drug stocks facing key FDA drug approval decisions in 2012.

Insiders Trading TXI, P, NGSX, CNK

The top 10 open-market insider purchases and sales filed at the SEC Monday.

Breaking News

'Big Short' Burry Warns That a Repeat of the 2008 Crisis Is in Sight

The legendary financier reiterates his warnings of a market collapse on the way.

Elon Musk Says a Tesla Catgirl Robot Is Coming

This machine is expected to be produced "as quickly as possible" at a high volume and at low cost.

McDonald's Menu Adds a (Very) New Take on an Old Favorite

The fast-food giant has been hesitant to make changes like this, but Wendy's bold move may have forced it to.

Everything Elon Musk Said At Tesla AI Day to Sell His Vision

The billionaire wants to create a "future of abundance" by mass-producing humanoid robots.